Literature DB >> 29797101

Considerations for the Use of Polysorbates in Biopharmaceuticals.

Michael T Jones1, Hanns-Christian Mahler2, Sandeep Yadav3, Dilbir Bindra4, Vincent Corvari5, R Matthew Fesinmeyer6, Kapil Gupta7, Alexander M Harmon8, Kenneth D Hinds8, Atanas Koulov2, Wei Liu8, Kevin Maloney7, John Wang3, Ping Y Yeh6, Satish K Singh2.   

Abstract

PURPOSE: Polysorbates are commonly added to protein formulations and serve an important function as stabilizers. This paper reviews recent literature detailing some of the issues seen with the use of polysorbate 80 and polysorbate 20 in protein formulations. Based on this knowledge, a development strategy is proposed that leads to a control strategy for polysorbates in protein formulations.
METHODS: A consortium of Biopharmaceutical scientists working in the area of protein formulations, shared experiences with polysorbates as stabilizers in their formulations.
RESULTS: Based on the authors experiences and recent published literature, a recommendation is put forth for a development strategy which will lead into the appropriate control strategy for these excipients.
CONCLUSIONS: An appropriate control strategy may comprise one or more elements of raw material, in-process and manufacturing controls. Additionally, understanding the role, if any, polysorbates play during stability will require knowledge of the criticality of the excipient, based upon its impact on CQAs due to variations in concentration and degradation level.

Entities:  

Keywords:  PS20; PS80; control strategy; polysorbate; protein formulations

Mesh:

Substances:

Year:  2018        PMID: 29797101     DOI: 10.1007/s11095-018-2430-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  48 in total

1.  Inverse relationship of protein concentration and aggregation.

Authors:  Michael J Treuheit; Andrew A Kosky; David N Brems
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations.

Authors:  Troii Hall; Stephanie L Sandefur; Christopher C Frye; Tammy L Tuley; Lihua Huang
Journal:  J Pharm Sci       Date:  2016-04-05       Impact factor: 3.534

3.  Surface-induced denaturation of proteins during freezing and its inhibition by surfactants.

Authors:  B S Chang; B S Kendrick; J F Carpenter
Journal:  J Pharm Sci       Date:  1996-12       Impact factor: 3.534

4.  Degradation Mechanisms of Polysorbate 20 Differentiated by 18O-labeling and Mass Spectrometry.

Authors:  Lin Zhang; Sandeep Yadav; Barthélemy Demeule; Y John Wang; Olivier Mozziconacci; Christian Schӧneich
Journal:  Pharm Res       Date:  2016-10-13       Impact factor: 4.200

5.  Quantitation of low concentrations of polysorbates in high protein concentration formulations by solid phase extraction and cobalt-thiocyanate derivatization.

Authors:  Justin Kim; Jinshu Qiu
Journal:  Anal Chim Acta       Date:  2013-11-15       Impact factor: 6.558

6.  The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics.

Authors:  Ravuri S K Kishore; Sylvia Kiese; Stefan Fischer; Astrid Pappenberger; Ulla Grauschopf; Hanns-Christian Mahler
Journal:  Pharm Res       Date:  2011-03-03       Impact factor: 4.200

7.  Degradation of polysorbates 20 and 80: studies on thermal autoxidation and hydrolysis.

Authors:  Ravuri S K Kishore; Astrid Pappenberger; Isabelle Bauer Dauphin; Alfred Ross; Beatrice Buergi; Andreas Staempfli; Hanns-Christian Mahler
Journal:  J Pharm Sci       Date:  2010-08-27       Impact factor: 3.534

8.  Mixed-mode and reversed-phase liquid chromatography-tandem mass spectrometry methodologies to study composition and base hydrolysis of polysorbate 20 and 80.

Authors:  Daniel Hewitt; Melissa Alvarez; Kathryn Robinson; Junyan Ji; Y John Wang; Yung-Hsiang Kao; Taylor Zhang
Journal:  J Chromatogr A       Date:  2010-09-29       Impact factor: 4.759

9.  Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at -20 degrees C of a recombinant hemoglobin.

Authors:  B A Kerwin; M C Heller; S H Levin; T W Randolph
Journal:  J Pharm Sci       Date:  1998-09       Impact factor: 3.534

10.  Determination of the critical micelle concentration of surfactants using the fluorescent probe N-phenyl-1-naphthylamine.

Authors:  R M Brito; W L Vaz
Journal:  Anal Biochem       Date:  1986-02-01       Impact factor: 3.365

View more
  2 in total

1.  Pediatric Safety of Polysorbates in Drug Formulations.

Authors:  Christina Kriegel; Matthias Festag; Ravuri S K Kishore; Dieter Roethlisberger; Georg Schmitt
Journal:  Children (Basel)       Date:  2019-12-20

2.  Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants.

Authors:  Catherine M Moore; Melanie Grandits; Clemens Grünwald-Gruber; Friedrich Altmann; Maria Kotouckova; Audrey Y-H Teh; Julian K-C Ma
Journal:  Retrovirology       Date:  2021-06-28       Impact factor: 4.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.